Last updated: May 20, 2025
Sponsor: Shanghai Chest Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cancer Treatment
Cancer
Chemotherapy
Treatment
Targeted Therapy Agent
immunotherapy
Clinical Study ID
NCT06218901
THORACIC005
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Histologically proven diagnosis of lung cancer
18 years of age or older
Ability to understand and the willingness to sign a written informed consentdocument
Exclusion
Exclusion Criteria:
- Not willing to participate in this clinical trial
Study Design
Total Participants: 500
Treatment Group(s): 2
Primary Treatment: Targeted Therapy Agent
Phase:
Study Start date:
January 01, 2016
Estimated Completion Date:
December 31, 2028
Connect with a study center
Shanghai Chest Hospital
Shanghai, Shanghai 200030
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.